alexa How To Innovate In Medicine In A University Setting? The Crucial Role Of Venture Capital Funds And Ethical Angel Investors’ Networks: Bio-cube Istanbul Bioentrepreneurship And Innovation Center As A Global Case Example | 109205
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page

How to innovate in medicine in a university setting? The crucial role of venture capital funds and ethical angel investors’ networks: Bio-cube Istanbul bioentrepreneurship and innovation center as a global case example


Yavuz Selim Silay

Maqasid Angel Investors Network, Turkey

ScientificTracks Abstracts: Clin Pharmacol Biopharm

Abstract
Large pharmaceutical, biotech and medical device companies are constantly evaluating how to work with universities and startup companies and utilize. Istanbul Consulting Group recently worked with Istanbul Ayd?n University to establish a thematic program in Healthcare Bioentrepreneurship which has taken the road with the slogan of“Towards a Bright Future”, at the brightest spots of business life. Istanbul Ayd?n University is a city and campus university located in the center of Istanbul with its experienced academic staff who have gained a reputation for their scientific studies globally. At BioCube Istanbul several healthcare startup companies are flourishing thanks to the coordination of technology transfer and project management offices successful coordination on innovation management with all key stakeholders. To gain these critical insights for thematic management of healthcare bioentrepreneurship and innovation track in universities and how to accelerate innovations in order to improve healthcare. We seek to empower entrepreneur academicians, doctors, other healthcare providers and with the information, resources, connections and experience they need to commercialize their ideas, inventions and discoveries. Current trends in innovation management in medicine in a university setting and the BioCube Istanbul Bioentrepreneurship and Innovation Center as a global case for USA, Europe, Turkey and emerging markets will be provided with unique cases. Dr. Yavuz Selim Silay a global physician leader and seasoned expert in Healthcare Innovation, Physician Entrepreneurship, Government engagement, Commercial Diplomacy, Corporate Communications, Government affairs & Medical Affairs will discuss how BioCube ?stanbul has been established and current engagements with academicians venture capital and angel investment networks for commercializing healthcare technologies will be discussed.
Biography

Yavuz Selim Silay is the Co-Founder & CEO of MaQasid Angel Investors Network (MAIN) and Chairman of Istanbul Consulting Group. He is currently the Co-Founder of BioCube İstanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Archem Diagnostics. He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and Director of Avcılar Hospital R&D Center. Previously he has worked as the Market Access & Health Policy Director for AIFD in Turkey. He has previously worked as the Vice President of Ipsen Pharmaceutical and Director of Teva Pharmaceutical in USA managing large clinical trials as well as Investigator initiated trials and developing relationships with key opinion leaders. He was the Associate Director at KV Pharmaceuticals and Director in Clinical Development Department at Forest Laboratories. He has earned his MD from the Faculty of Medicine, University of Ankara in Ankara, Turkey. He has completed a Clinical Internship at Baylor College of Medicine in Houston, followed by continued research training at The University of Texas MD Anderson Cancer Center in Houston. He recently completed his Executive MBA at the Olin Business School at Washington University in St. Louis.

Top